Opportunity Wisconsin Urges Rep. Steil to Oppose Inflation Act Repeal
Opportunity Wisconsin’s mobile billboard campaign targeted Congressman Bryan Steil, criticizing his opposition to capping prescription drug costs for seniors on Medicare, a policy included in the Inflation Reduction Act. Steil has a history of voting against similar legislation such as the Affordable Insulin Now Act, which aimed to cap the cost of insulin at $35. The report also noted that Steil received over $100,000 in campaign contributions from the pharmaceutical industry and that Republicans are continuing to advocate for repealing the Inflation Reduction Act, which would increase costs for US citizens.
Kenosha Residents Informed of Congressman Steil’s Opposition to Prescription Drug Cost Cap
Over the holiday weekend, families in Kenosha, Wisconsin, were greeted by a Grinch-themed mobile billboard from Opportunity Wisconsin. The billboard highlighted Congressman Bryan Steil’s opposition to caps on prescription drug costs for Medicare seniors as part of the Inflation Reduction Act.
The Inflation Reduction Act, which Congressman Steil voted against, reduced health care and prescription drug costs for millions of Americans. It included a cap on out-of-pocket prescription drug expenses for Medicare recipients and a $35 monthly cap on insulin prices.
Steil’s opposition to the Inflation Reduction Act is the latest in a series of voting patterns that favor high insulin prices. He also voted against the Affordable Insulin Now Act, a legislation designed to cap insulin costs at $35.
In addition to opposing these cost-reduction initiatives, Steil has accepted over $100,000 in campaign contributions from the pharmaceutical industry.
Legislation such as H.R. 812 has been introduced in the House of Representatives to repeal the Inflation Reduction Act, potentially raising costs for millions of Americans.
Holiday events and shopping areas in Kenosha were the venues where Steil’s constituents saw the mobile billboard.
Read More US Economic News